Bone Metabolism in Ovariectomized Rats with Induced Hyperthyroidism: The Effect of Estrogen Replacement

Volkan Sozer；Hafize Uzun；Ibrahim Guner；Seval Aydin；Rifat Yucel；Yesari Karter；Cahit Simsek；Safiye Kaya；Gunnur Yigit；Gonul Simsek

hyperthyroidism ； ovariectomy ； bone metabolism ； interleukin-1β ； interleukin-6 ； tumor necrosis factor-α ； estrogen replacement

The Chinese Journal of Physiology

49卷6期（2006 / 12 / 01）

335 - 341

英文

We aimed to investigate whether or not the estrogen is playing any role in the effect of thyroid hormones on bone metabolism. The rats were divided into five groups. In the first group L-thyroxine-induced hyperthyroid rats were ovariectomized (OVX) while the OVX rats were administered L-thyroxine in the second group. 17β-Estradiol (E2) was replaced in OVX rats in Group III. L-thyroxine and E2 were simultaneously administered to OVX rats in Group IV. The fifth group received sham operation. Blood samples taken from the tail vein of rats were analyzed for plasma T3, T4, TSH and serum interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)α, calcium (Ca), phosphorous (P), parathyroid hormone (PTH), alkaline phosphatase (t-ALP), bone-specific alkaline phosphatase (b-ALP) and E2. The levels of cytokines, t-ALP and b-ALP increased but PTH decreased, while there was no change in Ca and P levels in L-thyroxine-administrated rats. However, the levels of cytokines, Ca, P, PTH, t-ALP and b-ALP did not change in L-thyroxine-administered OVX rats. In OVX rats, the cytokines, t-ALP and b-ALP increased while Ca, P remained the same, but PTH decreased. L-thyroxine administration to OVX rats did not change the cytokines, Ca, P, PTH, t-ALP and b-ALP levels. The replacement of E2 in OVX rats decreased the cytokines, t-ALP and b-ALP values, increased PTH levels while there was no change in Ca and P. L-thyroxine and E2 administration to OVX rats increased the cytokines, t-ALP and b-ALP levels and decreased PTH, but Ca and P remained the same. In sham-operated rats, there was no change in all parameters compared to initial values. This study suggests that estrogen may play a role in the effects of thyroid hormones on bone metabolism.

1. Simsek, G.,Karter, Y.,Aydin, S.,Uzun, H.(2003).Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a results of reversal to euthyroidism.Chinese J. Physiol.,46,181-186.
   連結：
2. Simsek, G.,Yelmen, N.K.,Guner, I.,Sahin, G.,Oruc, T.,Karter, Y.(2004).The role peripheral chemoreceptor activity on the respiratory responses to hypoxia and hypercapnia in anaesthetised rabbits with induced hypothyroidism.Chinese J. Physiol.,47,153-160.
   連結：
3. Allain, T.J.,Chambers, T.J.,Flanagan, A.M.,McGregor, A.M.(1992).Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect.J. Endocrinol,133,331-334.
4. Baran, D.T.(1994).Detrimental skeletal effects of thyrotropin suppressive doses of thyroxine: fact or fantasy?.J. Clin. Endocrinol. Metab.,78,816-817.
5. Bernard-Poenaru, O.,Roux, C.,Blanque, R.,Gardner, C.,deVemejoul, M.C.,Cohen-Solal, M.E.(2001).Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study.Osteoporosis Int.,12,769-776.
6. Bisbocci, D.,Gallo, V.,Damiano, P.,Sidoli, L.,Cantoni, R.,Aimo, G.,Priolo, G.,Pagni, R.,Chiandussi, L.(1996).Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy.J. Endocrinol. Invest.,19,511-515.
7. Bouillon, R.,Muls, E.,De Moor, P.(1980).Influence of thyroid function on the serum concentration of 1,25 dihidroxyvitamin D3.J. Clin. Endocrinol. Metab.,51,793-797.
8. Buergi, U.,Larsen, P.R.(1982).Nuclear triiodothyronine binding in mononuclear leukocytes in normal subject and obese patients before and after fasting.J. Clin. Endocrinol. Metab,54,1199-1205.
9. Burman, K.D.,Monchick, J.M.,Earl, J.M.,Wartofsky, L.(1976).Ionized and total serum calcium and parathyroid hormone in hyperthyroidism.Ann. Intern. Med.,84,668-671.
10. Dick, I.M.,St John, A.,Heal, S.,Prince, R.L.(1996).The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat.Calsif. Tissue Int.,59,174-178.
11. Ericsen, E.F.,Kessem, M.(1992).The cellular basis of bone remodeling.J. Med. Sci.,31,45-57.
12. Ford, H.C.,Crooke, M.J.,Murphy, C.E.(1989).Disturbances of calcium and magnesium metabolism occur in most hyperthyroid patients.Clin. Biochem,22,373-376.
13. Garnero, P.,Vassy, V.,Bertholin, A.,Riou, J.P.,Delman, P.D.(1994).Markers of bone turnover in hyperthyroidism and the effect of treatment.J. Clin. Endocrinol. Metab.,78,955-959.
14. Girasole, G.,Jilka, R.L.,Passeri, G.,Boswell, S.,Boder, G.,Williams, D.C.,Manolagas, S.C.(1992).17 Beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potentia mechanism for the antiosteoporotic effect of estrogens.J. Clin. Invest.,89,883-891.
15. Hukkanen, M.,Platts, L.A.M.,Laves, T.,Girgis, S.I.,Kanttinen, Y.T.,Goodship, A.E.,Maclntyre, I.,Polak, J.M.(2003).Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia.Bone,32,142-149.
16. Institute of Laboratory animal resources commission on life sciences national research council(1996).National Research Council.Washington, D.C.:Animals housing and management.
17. Kawaguchi, H.,Pilbeam, C.C.,Vargas, S.J.,Mose, E.E.,Lorenzo, J.A.,Raisz, L.G.(1995).Ovariectomy enhances and estrogen replacement inhibits the activity of bone morrow factors that stimulate prostaglandin production in cultured mouse calvariae.J. Clin. Invest.,96,539-548.
18. Khosla, S.,Peterson, J.M.,Egan, K.,Jones, J.D.,Riggs, L.(1994).Circulating cytokine levels in osteoporotic and normal women.J. Clin. Endocrinol. Metab.,79,707-711.
19. Kim, C.H.,Kim, H.K.,Shang, Y.K.,Lee, K.U.,Kim, G.S.(1999).Thyroid hormone stimulates basal and interleukin (IL)-1 induced IL-6 production in human bone marrow stromal cells: a possible mediator of thyroid hormone-induced bone loss.J. Endocrinol,160,97-102.
20. Koka, S.,Petro, T.M.,Reinhardt, R.A.(1998).Estrogen inhibits interleukin-1 beta-induced interleukin-6 production by human osteoblast- like cells.J. Interferon Cytokine Res.,18,479-483.
21. Kurihara, N.,Bertolini, D.,Sida, T.,Akiyama, Y.,Roodman, G.D.(1990).IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release.J. Immunol,144,4226-4230.
22. Lakatos, P.,Foldes, J.,Horvath, C.,Kiss, L.,Tatrai, A.,Tarjan, G.,Stern, P.H.(1997).Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.J. Clin. Endocrinol. Metab,82,78-81.
23. Manolagas, S.C.,Jilka, R.L.(1995).Bone marrow, cytokines, and bone remodeling. Emerging insights into pathophysiology of osteoporosis.N. Engl. J. Med.,232,305-311.
24. Mosikilde, L.,Ericsen, E.F.,Charles, P.(1990).Effects of thyroid hormones on bone and mineral metabolism.Endocrinol. Matab. Clin. North Am.,19,35-63.
25. Pacifici, R.,Brown, C.,Puscheck, E.,Friedrich, E.,Slatopolsky, E.,Maggio, D.,McCraken, R.,Avioli, L.V.(1991).Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells.Proc. Natl. Acad. Sci. USA.,15,5134-5138.
26. Pacifici, R.,Rifas, L.,Teitelbaum, S.,Slatopolsky, E.,McCraken, R.,Bergfeld, M.,Lee, W.,Avioli, L.V.,Peck, W.A.(1987).Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis.Proc. Natl. Acad. Sci. USA.,84,4616-4620.
27. Passeri, G.,Girasole, G.,Jilka, R.L.,Manolagas, S.C.(1993).Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal.Endocrinology,133,822-828.
28. Pottratz, S.T.,Bellido, T.,Mocharla , H.,Crabb, D.,Manolagas, S.C.(1994).17 Beta-estradiol inhibits expression of human interleukin-6 promoter-receptor constructs by a receptor-dependent mechanism.J. Clin. Invest.,93,944-950.
29. Pumarino, H.,Pumarino, M.G.(1996).Cytokines, growth factors, and metabolic bone disease.Rev. Med. Chil.,124,248-257.
30. Reinhardt, R.A.,Masada, M.P.,Payne, J.P.,Allison, A.C.,Dubois, L.M.(1994).Gingival fluid IL-1 beta and IL-6 levels in menopause.J. Clin. Periodontol,21,22-25.
31. Riggs, B.L.,Khosla, S.,Melton, L.J.(1998).Aunitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.J. Bone Miner. Res.,13,763-773.
32. Rizzoli, R.,Poser, J.,Burgi, U.(1986).Nuclear thyroid hormone receptors in cultured bone cells.Metabolism,35,71-74.
33. Schaffer, R.B.,Gregory, D.H.(1972).Calcium malabsorption in hyperthyroidism.Gastroenterology,63,235-239.
34. Schneider, D.L.,Barrett-Connor, E.L.(1997).Urinary N-telopeptide levels discriminate normal, osteoporotic bone mineral density.Arch. Intern. Med.,157,1241-1245.
35. Siddiqi, A.,Burrin, J.M.,Wood, D.F.,Monson, J.P.(1998).Triiodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells.J. Endorinol,157,453-461.
36. Siddiqi, A.,Monson, J.P.,Wood, D.F.,Besser, G.M.,Burrin, J.M.(1999).Serum cytokines in thyrotoxicosis.J. Clin. Endokrinol. Metab,84,435-439.
37. Simsek, G.,Andican, G.,Unal, E.,Hatemi, H.,Yigit, G.,Candan, G.(1997).Calcium, magnesium, and zinc status in experimental hyperthyroidism.Biol. Trace. Elem. Res.,57,131-137.
38. Simsek, G.,Aydin, S.,Uzun, H.,Karter, Y.,Yigit, G.,Dondurmacι, S.,Hatemi, H.(1997).The role of cytokines in bone metabolism of rats with induced hyperthyroidism.Med. Sci. Res.,25,421-423.
39. Simsek, G.,Uzun, H.,Aydin, S.,Karter, Y.,Benian, A.,Dariyerli, N.,Kaya, S.,Yigit, G.(2005).The role of nitric oxide on bone metabolism in ovariectomized rats following chronic ethanol intake.Life Sci.,76,1965-1974.
40. Simsek, G.,Uzun, H.,Karter, Y.,Aydin, S.,Yigit, G.(2003).Effects of osteoporotic cytokines in ovary-intact and ovariectomised rats with induced hyperthyroidism; is skeletal responsiveness to thyroid hormone altered in estrogen deficiency?.Tohoku J. Exp. Med.,201,81-89.
41. Toh, S.H.,Claunch, B.C.,Brown, P.H.(1985).Effect of hyperthyroidism and its treatment on bone mineral content.Arch. Intern. Med.,145,883-886.
42. Turner, R.T.,Riggs, B.L.,Spelsberg, T.C.(1994).Skeletal effects of estrogen.Endocr. Rev.,15,275-300.
43. Zeni, S.,Gomez-Acotto, C.,Mautalen, C.(1997).The effect of olpadronate in ovariectomized thyroxine-treated rats.Bone,21,329-333.

1. Wang, Ming-Fu,Liu, Mei-Hui,Chen, Chun-Chi,Chen, Cheng-Chin(2007).Effects of Aging and Dietary Antler Supplementation on the Calcium-Regulating Hormones and Bone Status in Ovariectomized SAMP8 Mice.Chinese Journal of Physiology,50(6),308-314.